PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 28867741-3 2017 These findings suggest that the inhibition of PEPT1, which were up-regulated in inflamed or non-inflamed site on UC and CD patients, contribute to the clinical effect of commercially available drugs for IBD patients through the inhibition of uptake of antigenic proinflammatory oligopeptides such as formyl-methionine (Met)-leucine (Leu)-phenylalanine (Phe) via PEPT1. Phenylalanine 353-356 solute carrier family 15 member 1 Homo sapiens 46-51 28867741-3 2017 These findings suggest that the inhibition of PEPT1, which were up-regulated in inflamed or non-inflamed site on UC and CD patients, contribute to the clinical effect of commercially available drugs for IBD patients through the inhibition of uptake of antigenic proinflammatory oligopeptides such as formyl-methionine (Met)-leucine (Leu)-phenylalanine (Phe) via PEPT1. Phenylalanine 353-356 solute carrier family 15 member 1 Homo sapiens 362-367 26590007-2 2016 Among the quinolones examined, lomefloxacin, moxifloxacin (MFLX) and purlifloxacin significantly inhibited the uptake of PEPT1 substrate phenylalanine-Psi(CN-S)-alanine (Phe-Psi-Ala) in HeLa/PEPT1 cells to 31.6 +- 1.3%, 27.6 +- 2.9%, 36.8 +- 2.2% and 32.6 +- 1.4%, respectively. Phenylalanine 137-150 solute carrier family 15 member 1 Homo sapiens 121-126 26590007-2 2016 Among the quinolones examined, lomefloxacin, moxifloxacin (MFLX) and purlifloxacin significantly inhibited the uptake of PEPT1 substrate phenylalanine-Psi(CN-S)-alanine (Phe-Psi-Ala) in HeLa/PEPT1 cells to 31.6 +- 1.3%, 27.6 +- 2.9%, 36.8 +- 2.2% and 32.6 +- 1.4%, respectively. Phenylalanine 137-150 solute carrier family 15 member 1 Homo sapiens 191-196 26590007-2 2016 Among the quinolones examined, lomefloxacin, moxifloxacin (MFLX) and purlifloxacin significantly inhibited the uptake of PEPT1 substrate phenylalanine-Psi(CN-S)-alanine (Phe-Psi-Ala) in HeLa/PEPT1 cells to 31.6 +- 1.3%, 27.6 +- 2.9%, 36.8 +- 2.2% and 32.6 +- 1.4%, respectively. Phenylalanine 170-173 solute carrier family 15 member 1 Homo sapiens 121-126 10848990-5 2000 Ac-Phe-NH2 had a very weak interaction with PepT1 (Ki = 16.8+/-5.64 mM); neither Phe nor Phe-NH2 interacted with PepT1 with measurable affinity. Phenylalanine 3-6 solute carrier family 15 member 1 Homo sapiens 44-49 23735006-3 2013 Herein the structure-activity relationship (SAR) of a set of modified H-Phe-Phe-NH2 analogues is presented together with their potential active uptake by PEPT1 transporter, intestinal permeability, and metabolic stability. Phenylalanine 72-75 solute carrier family 15 member 1 Homo sapiens 154-159 23735006-3 2013 Herein the structure-activity relationship (SAR) of a set of modified H-Phe-Phe-NH2 analogues is presented together with their potential active uptake by PEPT1 transporter, intestinal permeability, and metabolic stability. Phenylalanine 76-79 solute carrier family 15 member 1 Homo sapiens 154-159 17932227-8 2007 Mutational analysis showed that phenylalanine 293, phenylalanine 297, and threonine 281 in transmembrane segment 7 of the human di/tripeptide transporter, hPepT1, are important for the targeting to lipid rafts and transport activity of hPepT1. Phenylalanine 32-45 solute carrier family 15 member 1 Homo sapiens 155-161 17932227-8 2007 Mutational analysis showed that phenylalanine 293, phenylalanine 297, and threonine 281 in transmembrane segment 7 of the human di/tripeptide transporter, hPepT1, are important for the targeting to lipid rafts and transport activity of hPepT1. Phenylalanine 32-45 solute carrier family 15 member 1 Homo sapiens 236-242 17932227-8 2007 Mutational analysis showed that phenylalanine 293, phenylalanine 297, and threonine 281 in transmembrane segment 7 of the human di/tripeptide transporter, hPepT1, are important for the targeting to lipid rafts and transport activity of hPepT1. Phenylalanine 51-64 solute carrier family 15 member 1 Homo sapiens 155-161 17932227-8 2007 Mutational analysis showed that phenylalanine 293, phenylalanine 297, and threonine 281 in transmembrane segment 7 of the human di/tripeptide transporter, hPepT1, are important for the targeting to lipid rafts and transport activity of hPepT1. Phenylalanine 51-64 solute carrier family 15 member 1 Homo sapiens 236-242 9126331-3 1997 Functional expression of PepT1 was determined in different recombinant clones by flux studies employing the radiolabeled dipeptide 3H-(D)-Phe-(L)-Ala. One clone (GS-PepT1) displayed high level functional expression that was pH dependent and saturable with an app. Phenylalanine 138-141 solute carrier family 15 member 1 Homo sapiens 25-30